Back

Diastolic hyperemia-free ratio for the assessment of intermediate coronary artery stenosis in patients with hemodialysis

30 August 2024 (12:00 - 12:50)
Organised by: Logo
Congress Presentation Part of: Anatomic and physiological considerations in coronary syndromes Intracoronary Flow and Pressure Measurements ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Hiroaki Nohara

Osaka Rosai Hospital, Sakai (Japan)

7 More presentations in this session

Presentation thumbnail
Accuracy of machine learning techniques to predict stress echocardiography results using clinical variables
Doctor U. Ihekwaba (Milton Keynes, GB)
Abstract Slides Video
Presentation thumbnail
Chronic Coronary Syndromes with/without obstructive coronary arteries: are there differences in ongoing chest pain?
Ms S. La (Adelaide, AU)
Abstract Slides
Presentation thumbnail
Initial results of the READY registry: comparison of visual and physiological lesion characterization and the effect of hydrostatic pressure correction
Doctor A. Agoston (Nyiregyhaza, HU)
Abstract Slides Video
Presentation thumbnail
ClinicAl verSus algorIthmic predictioN of Obstructive Coronary Artery Disease - the CASINO study
Doctor M. Paiva (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Testing the accuracy of automatic ECG-annotation for suspected acute coronary syndrome
Doctor L. Sams (Munich, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Anatomic and physiological considerations in coronary syndromes

The Event

Event poster

ESC Congress 2024

30 August 2024 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Relationship between diastolic hyperemia-free ratio and fractional flow reserve in patients with aortic valve stenosis
thumbnail
Congress Presentation
Impact of coronary flow reserve on the mortality and major adverse cardiac and cerebrovascular event in hemodialysis patients, regardless of diabetes.
thumbnail
Congress Session
Functional testing in coronary artery disease

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources